AUROBINDO PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Quarterly Results   (AUBD)

Here are the latest quarterly results of AUROBINDO PHARMA. For more details, see the AUROBINDO PHARMA financial fact sheet and AUROBINDO PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

AUROBINDO PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
3
Dec-21
*
3
Mar-22
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m59,24864,83463,64960,01557,02059,41960,02258,094 
Other income Rs m1,1565381,3347811,099966650489 
Turnover Rs m60,40465,37264,98360,79658,11960,38560,67258,583 
Expenses Rs m46,67450,50649,96347,26844,92647,55249,86048,350 
Gross profit Rs m12,57414,32841,82512,75412,09411,86710,5118,116 
Depreciation Rs m2,5552,5732,7652,6602,7972,9422,9912,536 
Interest Rs m21115719518212910416192 
Profit before tax Rs m10,96412,13540,19910,69210,2679,7878,0095,977 
Tax Rs m3,0123,85710,5752,5972,4772,7091,895175 
Profit after tax Rs m7,9528,27829,6248,0967,7907,0786,1145,803 
Gross profit margin %21.222.165.721.321.220.017.514.0 
Effective tax rate %27.531.826.324.324.127.723.72.9 
Net profit margin %13.412.846.513.513.711.910.210.0 
Diluted EPS Rs 13.6 14.1 50.6 13.8 13.3 12.1 10.4 9.9  
Diluted EPS (TTM) Rs 51.6 54.8 93.3 92.1 91.8 89.7 49.6 45.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today's Market

Indian Share Markets End Flat; Tech Mahindra, IndusInd Bank & Bajaj Finance Top Losers(Closing)

Indian share markets traded in a rangebound fashion throughout the day today to end flat.

Views on news

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

The Greatest Dividend Stock of All Time is... (Views On News)

Jun 16, 2022

Prudent investors should consider dividend aristocrats to create passive, predictable, and growing income to rely on whether the market moves up or down in these uncertain times.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Jun 30, 2022 03:29 PM

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - ZIM LABORATORIES COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS